|
In addition to pioneering read-through motion and low perfusion pulse oximetry, Masimo was the first to introduce other breakthrough designs, including sensors with built-in intelligence. Below are two specialty sensor lines featuring this sophisticated technology.
The LNOP Newborn sensor is specifically designed with newborn resuscitation in mind. When the Newborn sensor is connected to Masimo-equipped technology version 4.1 or higher, it automatically enables the fastest SpO2 and pulse rate readings at maximum sensitivity. In addition to providing optimal performance, the Newborn sensor allows quick application. With a unique combination of a VelAid™ SofTouch® hook-and-loop attachment, and adhesive emitter and detector strip, the sensor stays secure even when the site is wet. The Masimo LNOP Newborn sensor allows clinicians to focus their attention on their patients instead of using valuable seconds configuring the monitor to deliver the performance they need during critical situations.
|
Neonatal, infant, and pediatric patients with congenital heart disease have unique physiology, which has frequently made it impossible for clinicians to obtain reliable pulse oximetry readings. This limitation has impacted the clinicians’ ability to rely on continuous SpO2 measurements to determine the precise cardiac medication and ventilatory management these patients require. After extensive research and development, Masimo introduced LNOP Blue, the first and only adhesive sensor proven accurate on pediatric patients with congenital heart disease with saturations as low as 60%.1 LNOP Blue provides clinicians with the reliable, continuous pulse oximetry they need to better manage the cardiac medications and ventilation therapy of these critical patients.
1 Whitney GM, Tucker LR, Hall SR, Chang AC. Clinical evaluation of the accuracy of Masimo SET and Nellcor N-595 oximeters in children with cyanotic congenital heart disease. Anesthesiology 2005; 103:A1344. |
|
